DoST, PSAAI begin Covid vaccine 'mix and match' in Muntinlupa

by The Manila Times

Nov 30, 2021 12:12 am

THROUGH the Philippine Society for Allergy, Asthma and Immunology (PSAAI), the Department of Science and Technology (DoST) began the Covid-19 vaccine 'mix and match' clinical study in Muntinlupa on November 22.

The study aimed to determine the safety and immunogenicity of completing the vaccination series with different Covid-19 vaccines and vaccine platforms available in the Philippines.

Already have an active account? Log in here to continue reading.
Or
Subscribe to the Premium Subscription plan to access this subscriber-exclusive article.

Related Articles

Natura &Co shows improved revenue trends, with strong performance by Natura in Brazil and signs of stability at Avon in the country

Helzberg Diamonds and Proximity join forces to elevate customer experience

UNESCO Intangible Cultural Heritage "Bunraku" on World Stage: Japan's National Theatre to Present Spectacular Fusion of Tradition and Anime in United States

AdvoLogix Announces: AI-Enhanced Matter Financial Management for Law Firms

NFP Acquires Orca Financial Group, a Specialist Financial Brokerage

rabbit r1, the Consumer AI-native Pocket Companion, Expands Availability Across the UK and European Union

Infortrend U.2 NVMe Storage Empowers Airport AI for Faster Passenger Processing